SCHEMBL2224088

SCHEMBL2224088

CN1CCC(Nc2cc(S(=O)(=O)c3c[nH]c4cc(F)ccc34)ccc2Cl)CC1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 2/20 0.43
TDO2 P48775 11/20 0.43
CYP3A4 P08684 3/20 0.40
CYP2D6 P10635 2/20 0.40
DRD2 P14416 2/20 0.38
SLC6A2 P23975 2/20 0.38
HTR2A P28223 2/20 0.38
HTR2C P28335 2/20 0.38
HTR7 P34969 2/20 0.38
HRH1 P35367 2/20 0.38
ADRA1B P35368 2/20 0.38
SLC6A3 Q01959 2/20 0.38
GRM5 P41594 1/20 0.38
SLC6A4 P31645 1/20 0.38
HTR6 P50406 1/20 0.38
HTR1F P30939 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2223345 0.93 KCNH2 (0.45) KCNH2CYP3A4CYP2D6DRD2SLC6A2
SCHEMBL2222683 0.91 CYP3A4 (0.44) KCNH2CYP3A4CYP2D6DRD2SLC6A2
Hydrochloric Acid SCHEMBL2224877 0.90 CYP3A4 (0.43) KCNH2CYP3A4CYP2D6DRD2SLC6A2
SCHEMBL2266345 0.90 KCNH2 (0.43) KCNH2TDO2CYP3A4DRD2SLC6A4
SCHEMBL2226483 0.90 KCNH2 (0.47) KCNH2TDO2CYP3A4CYP2D6DRD2
SCHEMBL2222150 0.87 KCNH2 (0.58) KCNH2TDO2CYP3A4CYP2D6DRD2
SCHEMBL2221872 0.87 KCNH2 (0.42) KCNH2TDO2CYP3A4HTR6HTR1F
SCHEMBL2222211 0.85 KCNH2 (0.47) KCNH2TDO2CYP3A4CYP2D6DRD2
SCHEMBL2276442 0.84 KCNH2 (0.47) KCNH2TDO2CYP3A4HTR6HTR1F
SCHEMBL2222384 0.83 TDO2 (0.44) KCNH2TDO2HTR2AHTR2CHTR6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP claimed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO claimed
US-9018231-B2 Sulfone compounds as 5-HT6 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2015-04-28 US disclosed
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-01-03 US disclosed
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP disclosed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS HTR6, HTR5A, HTR1A KCNH2 2828/4885TDO2 229/4885CYP3A4 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.